Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer

(2014) V. W. Y. Lui et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer

(2013) Teng Ji et al.   CANCER LETTERS

The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas

(2013) Eleni Benson et al.   ORAL ONCOLOGY

Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer

(2012) M. Sen et al.   CLINICAL CANCER RESEARCH

Protein tyrosine phosphatase receptor-like genes are frequently hypermethylated in sporadic colorectal cancer

(2012) Izabela Laczmanska et al.   JOURNAL OF HUMAN GENETICS

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

(2010) L. Licitra et al.   ANNALS OF ONCOLOGY

Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas

(2008) Wentao Gao et al.   CARCINOGENESIS